Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Alprazolam measurement |
Component |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing alprazolam (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprazolam poisoning (disorder) |
Causative agent (attribute) |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental alprazolam poisoning |
Causative agent (attribute) |
False |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional alprazolam poisoning (disorder) |
Causative agent (attribute) |
False |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
intoxication par l'alprazolam d'intention indéterminée |
Causative agent (attribute) |
False |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprazolam adverse reaction |
Causative agent (attribute) |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to alprazolam |
Causative agent (attribute) |
False |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprazolam overdose |
Causative agent (attribute) |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental alprazolam overdose |
Causative agent (attribute) |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional alprazolam overdose |
Causative agent (attribute) |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
surdose d'alprazolam d'intention indéterminée |
Causative agent (attribute) |
False |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprazolam 250 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprazolam 500 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprazolam 1mg/ml concentrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely alprazolam 100 microgram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprazolam 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprazolam 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprazolam 250 microgram orodispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely alprazolam 500 microgram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprazolam 1 mg orodispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely alprazolam 2 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental alprazolam poisoning |
Causative agent (attribute) |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional alprazolam poisoning (disorder) |
Causative agent (attribute) |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Measurement of alprazolam in serum specimen |
Component |
False |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Allergy to alprazolam |
Causative agent (attribute) |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprazolam 250 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprazolam 250 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprazolam 500 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprazolam 500 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprazolam 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprazolam 1 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprazolam 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprazolam 2 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely alprazolam 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alprazolam 2 mg oral tablet |
Has precise active ingredient |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprazolam 250 microgram oral tablet |
Has precise active ingredient |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprazolam 500 microgram oral tablet |
Has precise active ingredient |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing alprazolam in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprazolam 1 mg oral tablet |
Has precise active ingredient |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprazolam only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprazolam only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely alprazolam 100 microgram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely alprazolam 100 microgram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely alprazolam 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely alprazolam 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely alprazolam 500 microgram/1 each conventional release orodispersible tablet (clinical drug) |
Has precise active ingredient |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely alprazolam 500 microgram/1 each conventional release orodispersible tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprazolam 250 microgram orodispersible tablet |
Has basis of strength substance (attribute) |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprazolam 250 microgram orodispersible tablet |
Has precise active ingredient |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely alprazolam 2 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has precise active ingredient |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely alprazolam 2 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprazolam 1 mg orodispersible tablet |
Has basis of strength substance (attribute) |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprazolam 1 mg orodispersible tablet |
Has precise active ingredient |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprazolam only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing alprazolam in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely alprazolam 1 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely alprazolam 1 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprazolam 500 microgram prolonged-release oral tablet |
Has precise active ingredient |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprazolam 500 microgram prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprazolam 250 microgram and propranolol hydrochloride 10 mg oral tablet |
Has precise active ingredient |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alprazolam 250 microgram and propranolol hydrochloride 10 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing alprazolam and propranolol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Alprazolam and propranolol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Alprazolam- and propranolol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only alprazolam and propranolol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely alprazolam 3 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely alprazolam 3 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Measurement of alprazolam in serum specimen |
Component |
True |
Alprazolam |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |